Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FNMVM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,021
Award facts
- Contract value 100% obligated
- $41,020.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded July 30, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, provides Keytruda (pembrolizumab) 100 mg/4 mL vials to support the Defense Logistics Agency's pharmaceutical supply chain. The contract carries a ceiling value of $41,020.75 under a firm fixed-price arrangement with an ultimate completion date of August 20, 2025. No set-aside designation was utilized for this award, indicating the vendor competed on an unrestricted basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.9 million and valid through November 2026. That overarching contract, part of the SPE2DB program, authorizes the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. Keytruda, an oncology therapeutic, represents the specialized pharmaceutical products that DMS Pharmaceutical Group regularly supplies to military medical installations as part of its established role as a critical vendor in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FNMVM?
SPE2DB25FNMVM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FNMVM worth?
The government has obligated $41,021 on SPE2DB25FNMVM.
Is contract SPE2DB25FNMVM an order under another contract?
Yes. SPE2DB25FNMVM is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMVM competed?
The extent of competition for SPE2DB25FNMVM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award